Your session is about to expire
← Back to Search
Hormone + Radiation Therapy for Prostate Cancer
Study Summary
This trial is testing two different intensities of hormone therapy and radiation therapy, comparing them to the current standard of care, in order to determine the best treatment plan for patients with high risk prostate cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My prostate cancer is aggressive (Gleason score 8-10).My cancer has spread to my lymph nodes, which are enlarged.I was diagnosed with prostate cancer less than 6 months ago.My cancer is classified as stage T3a to T4 based on exams or imaging.You have been granted an exemption from registration.
- Group 1: Arm II (de-intensification study)
- Group 2: Arm I (de-intensification study)
- Group 3: Arm III (intensification study)
- Group 4: Arm IV (intensification study)
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are we still enrolling people in this test program?
"That is correct. Based on the information available from clinicaltrials.gov, it appears as though this study is still recruiting patients for participation. The trial was originally posted on December 15th, 2020 and was last updated on August 11th, 2022. In total, the study plans to enroll 2478 patients at 100 different locations."
What are some other papers that mention Radiation Therapy in their research?
"There are currently 611 clinical trials underway that focus on investigating Radiation Therapy. Of these, 177 have reached Phase 3 status. Many of the studies related to this treatment are based in Minneapolis, Minnesota; however, there are 29085 locations running similar research programs."
What types of treatments is Radiation Therapy used most to help with?
"Radiation therapy is most commonly used to treat acute kidney failure, but it can also be used to help manage a number of other conditions like ulcerative colitis, varicella-zoster virus acute retinal necrosis, and subarachnoid block."
In how many different geographical areas is this trial being run?
"Presently, this trial is being conducted in 200 different locations, 100 of which are Duarte, Orange and Kansas City. Minimizing travel is important for potential participants, so please select the clinical site closest to you."
How many people are signed up to take part in this experiment?
"Yes, this is an ongoing clinical trial that is actively recruiting participants. The listing was posted on December 15th 2020 with the most recent update occurring on August 11th 2022. There are 2478 patients needed for this study which will take place at 100 different locations."
Does the FDA condone Radiation Therapy as an effective treatment method?
"We have given Radiation Therapy a safety score of 3. This is based on the fact that it is in Phase 3 trials, meaning there is evidence of its efficacy as well as multiple rounds of data supporting its safety."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger